American Well Corporation
General ticker "AMWL" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $99.3M (TTM average)
American Well Corporation follows the US Stock Market performance with the rate: 48.4%.
Estimated limits based on current volatility of 3.0%: low 11.90$, high 12.64$
Factors to consider:
- Total employees count: 562 (-35.9%) as of 2025
- Top business risk factors: History of losses, Regulatory and compliance, Cybersecurity threats, Technological changes, Acquisition/divestiture risks
- Current price 83.0% above estimated high
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.25$, 7.01$]
- 2026-12-31 to 2027-12-31 estimated range: [1.67$, 5.40$]
Financial Metrics affecting the AMWL estimates:
- Positive: with PPE of -0.8 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -88.68 <= 0.28
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of 23.00 > -0.64
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Industry inventory ratio change (median), % of -0.11 <= 0
Short-term AMWL quotes
Long-term AMWL plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $259.05MM | $254.36MM | $249.32MM |
| Operating Expenses | $951.19MM | $471.90MM | $354.60MM |
| Operating Income | $-692.14MM | $-217.53MM | $-105.27MM |
| Non-Operating Income | $19.42MM | $10.76MM | $10.74MM |
| R&D Expense | $105.83MM | $86.06MM | $72.86MM |
| Income(Loss) | $-672.72MM | $-206.78MM | $-94.53MM |
| Taxes | $3.86MM | $2.75MM | $0.43MM |
| Other Income(Loss) | $-2.59MM | $-3.11MM | $0.00MM |
| Net Income(Loss)* | $-672.57MM | $-205.03MM | $-95.70MM |
| Stockholders Equity | $464.22MM | $304.77MM | $235.58MM |
| Inventory | $6.65MM | $2.86MM | $1.19MM |
| Assets | $589.71MM | $435.97MM | $323.79MM |
| Operating Cash Flow | $-148.34MM | $-127.34MM | $-65.95MM |
| Capital expenditure | $15.25MM | $15.22MM | $0.02MM |
| Investing Cash Flow | $-19.17MM | $-18.65MM | $17.10MM |
| Financing Cash Flow | $2.15MM | $1.38MM | $0.84MM |
| Earnings Per Share** | $-47.32 | $-13.67 | $-5.96 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.